IP Library Granted Patent US 9,956,116
Granted Patent B2
US 9,956,116 · App. 14/376,235 · Granted May 1, 2018

Method and apparatus for treating an ocular disorder

Inventors: Davinder S. Grover (Dallas, TX); Ronald L. Fellman (Dallas, TX); David G. Godfrey (Dallas, TX)
Assignee: INNOVATIVE GLAUCOMA SOLUTIONS, LLC
A61F9/00781A61B5/065A61F9/007A61F9/0133A61F2009/00861A61F2009/00868A61F2009/00885A61F2009/00891
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,956,116
App. No.
14/376,235
Granted
May 1, 2018
Kind
B2
Abstract

Embodiments of the claimed invention are directed to the treatment of glaucoma (or conditions of elevated intraocular pressure) using a novel ab interno trabeculotomy procedure that uses a flexible device. At least one advantage of the present method is that it does not require a conjunctival or scleral incision, which in turn improves patient recovery time and healing.

Claims (20)

1. A method for performing a trabeculotomy ab intern, the method comprising the steps of

making at least one corneal incision,

placing a surgical instrument with a cutting edge through the corneal incision,

making an incision into the trabecular meshwork to access the lumen of Schlemm's canal,

placing the distal end of a device into the anterior chamber,

advancing the device within Schlemm's canal,

pulling the distal end of the device into the anterior chamber,

applying tension to the device within the canal by applying tension between the ends of the device within Schlemm's canal thereby rupturing the trabecular meshwork in the area cannulated by the device, and

withdrawing the device through the corneal incision.

2. The method of claim 1 , wherein the device is advanced along the full circumference of Schlemm's canal.

3. The method of claim 1 , where the device is advanced along Schlemm's canal for approximately 180 degrees and repeating the procedure to the remaining 180 degrees of the canal.

4. The method of claim 1 , where the device is inserted into Schlemm's canal while being visualized by a gonioprism.

5. The method of claim 1 , where the device is inserted into Schlemm's canal while being visualized by an endoscope placed in the anterior chamber.

6. The method of claim 1 , where the device comprises a lumen to inject fluid during cannulation of Schlemm's canal.

7. The method of claim 1 , where the device comprises a lighted tip to facilitate visualization of the tip location during cannulation of Schlemm's canal.

8. The method of claim 1 , where the device comprises a fiber optic.

9. The method of claim 1 , where the device comprises a curved tip.

10. The method of claim 9 , where the curved tip has a radius ranging from 2 to 4 mm.

11. The method of claim 1 , wherein the corneal incision is made to insert the distal end of the device into the anterior chamber, and a second corneal incision is made to retrieve the distal tip of the device.

12. The method of claim 1 where the corneal incision is made in the temporal quadrant of the eye.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2021
From: INNOVATIVE GLAUCOMA SOLUTIONS, LLC; NOVA EYE MEDICAL, LTD.
To: NOVA EYE, INC.
Reel/Frame 057741/0731 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2014
From: GROVER, DAVINDER S.; FELLMAN, RONALD L.; GODFREY, DAVID G.
To: INNOVATIVE GLAUCOMA SOLUTIONS, LLC
Reel/Frame 034265/0820 →
Continuity (2)
Provisional Application 61594502 · Feb 3, 2012
Related Publication 20150005623A1 · Jan 1, 2015